Smart Meter Corporation, a New York firm, won both FDA clearance and European CE Mark approval for its iGlucose system, a blood glucose meter that features built-in cellular connectivity. Diabetics using the iGlucose will have the convenience of seeing their readings automatically uploaded to the company’s web portal, from where their doctors and caretakers can check up on how things are going.
Blood glucose readings are shared with the cloud-based iGlucose Web Portal as soon as they’re taken, and from just about anywhere there is a cellular signal. Lifetime use of the cellular network is included with the device, so there is no subscription to pay for every month.
The glucometer needs only .75 µl of blood and provides results in just a few seconds and the company says its test strips are price competitive with popular strips on the market now.
When unusually high or low sugar levels are detected, the iGlucose Web Portal can be made to automatically send out alerts via email or text messages to the family and clinical team of the patient, helping to address issues quicker and before more serious consequences kick in.
An interesting feature of the iGlucose system is that it comes with an API (Application Program Interface), allowing outside developers to integrate their applications with the iGlucose. We’re glad to see this is becoming more common among medical device makers, helping to facilitate a more interconnected world of medical information.